{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:15:35Z","timestamp":1793229335764,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T00:00:00Z","timestamp":1695427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T00:00:00Z","timestamp":1695427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RO 5102\/1-2"],"award-info":[{"award-number":["RO 5102\/1-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"REBIRTH Center for Translational Regenerative Medicine through the State of Lower Saxony","award":["ZN3440"],"award-info":[{"award-number":["ZN3440"]}]},{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Mesenchymal stromal cells (MSCs) are excessively investigated in the context of inflammation-driven diseases, but the clinical results are often moderate. MSCs are naturally activated by inflammatory signals, which lead to the secretion of immune inhibitory factors in inflamed tissues. Many work groups try to improve the therapeutic outcome of MSCs by genetic modification and the constitutive overexpression of immune modulatory transgenes. However, the ectopic secretion of immune inhibitory transgenes increases the chances of infections, and constitutive transgene expression is not necessary for chronic diseases undergoing different inflammatory stages.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We designed and tested inflammation-induced promoters to control transgene expression from integrating lentiviral vectors in human umbilical cord MSCs. Therefore, we investigated different combinations of general transcription factor elements to achieve a minimal promoter with low basal activity. The best candidates were combined with interferon-induced GAS or ISRE DNA motifs. The constructs with the highest transgene expression upon addition of pro-inflammatory cytokines were compared to vectorized promoters from inflammation-induced genes (CD317, CXCL9, CXCL10, CXCL11 and IDO1). Finally, we investigated IL10 as a potential immune inhibitory transgene by transcriptome analyses, ELISA and in an acute lung injury mouse model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The synthetic promoters achieved a high and specific transgene expression upon IFN-\u03b3 addition. However, the CXCL11 promoter showed synergistic activity upon IFN-\u03b3, TNF-\u03b1 and IL1-\u03b2 treatment and surpassed the transgene expression height of all tested promoters in the study. We observed in transcriptome analyses that IL10 has no effect on MSCs and in ELISA that IL10 is only secreted by our genetically modified and activated CXCL11-IL10-MSCs. Finally, transplanted CXCL11-IL10-MSCs increased CD19+\u2009and CD4+\u2009lymphoid cells, and decreased CD11b+\u2009Ly6g myeloid cells in an ALI mouse model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>These results provide new insights into MSC inflammatory activation and the subsequent translation into a tool for a tailored expression of transgenes in inflammatory microenvironments. The newly developed promoter elements are potentially interesting for other inflamed tissues, and can be combined with other elements or used in other cell types.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-023-03501-6","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T08:30:14Z","timestamp":1695630614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Inflammation-inducible promoters to overexpress immune inhibitory factors by MSCs"],"prefix":"10.1186","volume":"14","author":[{"given":"Anton","family":"Selich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenni","family":"Fleischauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Roepke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Weisskoeppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Galla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"von Kaisenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich A.","family":"Maus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Schambach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6813-4705","authenticated-orcid":false,"given":"Michael","family":"Rothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,23]]},"reference":[{"key":"3501_CR1","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.3389\/fimmu.2018.02056","volume":"9","author":"A Leyendecker","year":"2018","unstructured":"Leyendecker A, Pinheiro CCG, Amano MT, Bueno DF. The use of human mesenchymal stem cells as therapeutic agents for the in vivo treatment of immune-related diseases: a systematic review. Front Immunol. 2018;9:2056.","journal-title":"Front Immunol"},{"key":"3501_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27472","author":"ME Cudkowicz","year":"2021","unstructured":"Cudkowicz ME, Lindborg SR, Goyal NA, Miller RG, Burford MJ, Berry JD, et al. A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis. Muscle Nerve. 2021. https:\/\/doi.org\/10.1002\/mus.27472.","journal-title":"Muscle Nerve"},{"key":"3501_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16468","author":"F Casiraghi","year":"2020","unstructured":"Casiraghi F, Perico N, Podest\u00e0 MA, Todeschini M, Zambelli M, Colledan M, et al. Third-party bone marrow-derived mesenchymal stromal cell infusion before liver transplantation: a randomized controlled trial. Am J Transplant. 2020. https:\/\/doi.org\/10.1111\/ajt.16468.","journal-title":"Am J Transplant"},{"key":"3501_CR4","doi-asserted-by":"publisher","first-page":"100454","DOI":"10.1016\/j.eclinm.2020.100454","volume":"25","author":"F S\u00e1nchez-Guijo","year":"2020","unstructured":"S\u00e1nchez-Guijo F, Garc\u00eda-Arranz M, L\u00f3pez-Parra M, Monedero P, Mata-Mart\u00ednez C, Santos A, et al. Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation a proof of concept study. EClinicalMedicine. 2020;25:100454.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"3501_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s13287-020-01826-0","volume":"11","author":"J Chen","year":"2020","unstructured":"Chen J, Zhang X, Xie J, Xue M, Liu L, Yang Y, et al. Overexpression of TGF\u03b21 in murine mesenchymal stem cells improves lung inflammation by impacting the Th17\/Treg balance in LPS-induced ARDS mice. Stem Cell Res Ther. 2020;11(1):311. https:\/\/doi.org\/10.1186\/s13287-020-01826-0.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"3501_CR6","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3390\/jcm8060847","volume":"8","author":"M Jerkic","year":"2019","unstructured":"Jerkic M, Masterson C, Ormesher L, Gagnon S, Goyal S, Rabani R, et al. Overexpression of IL-10 enhances the efficacy of human umbilical-cord-derived mesenchymal stromal cells in E coli Pneumosepsis. J Clin Med. 2019;8(6):847.","journal-title":"J Clin Med"},{"key":"3501_CR7","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2017.3735","author":"C Wang","year":"2017","unstructured":"Wang C, Lv D, Zhang X, Ni Z, Sun X, Zhu C. Interleukin-10-overexpressing mesenchymal stromal cells induce a series of regulatory effects in the inflammatory system and promote the survival of endotoxin-induced acute lung injury in mice model. DNA Cell Biol. 2017. https:\/\/doi.org\/10.1089\/dna.2017.3735.","journal-title":"DNA Cell Biol"},{"key":"3501_CR8","doi-asserted-by":"publisher","first-page":"2457082","DOI":"10.1155\/2019\/2457082","volume":"2019","author":"C Zhang","year":"2019","unstructured":"Zhang C, Zhu Y, Wang J, Hou L, Li W, An H. CXCR4-overexpressing umbilical cord mesenchymal stem cells enhance protection against radiation-induced lung injury. Stem Cells Int. 2019;2019:2457082.","journal-title":"Stem Cells Int"},{"issue":"8","key":"3501_CR9","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1182\/blood-2002-06-1830","volume":"101","author":"SM Devine","year":"2003","unstructured":"Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood. 2003;101(8):2999\u20133001.","journal-title":"Blood"},{"issue":"8","key":"3501_CR10","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1016\/j.burns.2020.05.012","volume":"46","author":"T Baljinnyam","year":"2020","unstructured":"Baljinnyam T, Radnaa E, Niimi Y, Fukuda S, Prough DS, Enkhbaatar P. Cutaneous burn diminishes beneficial effect of intravenously administered mesenchymal stem cells on acute lung injury induced by smoke inhalation in sheep. Burns. 2020;46(8):1914\u201323.","journal-title":"Burns"},{"issue":"10","key":"3501_CR11","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1212\/WNL.57.10.1885","volume":"57","author":"NL Sicotte","year":"2001","unstructured":"Sicotte NL, Voskuhl RR. Onset of multiple sclerosis associated with anti-TNF therapy. Neurology. 2001;57(10):1885\u20138. https:\/\/doi.org\/10.1212\/WNL.57.10.1885.","journal-title":"Neurology"},{"issue":"1","key":"3501_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1080\/030097402317255372","volume":"31","author":"L Mayordomo","year":"2002","unstructured":"Mayordomo L, Marenco JL, Gomez-Mateos J, Rejon E. Pulmonary miliary tuberculosis in a patient with anti-TNF-alpha treatment. Scand J Rheumatol. 2002;31(1):44\u20135. https:\/\/doi.org\/10.1080\/030097402317255372.","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"3501_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3899\/jrheum.121521","volume":"41","author":"VP Bykerk","year":"2014","unstructured":"Bykerk VP, Shadick N, Frits M, Bingham CO, Jeffery I, Iannaccone C, et al. Flares in rheumatoid arthritis: frequency and management. A report from the BRASS registry. J Rheumatol. 2014;41(2):227\u201334. https:\/\/doi.org\/10.3899\/jrheum.121521.","journal-title":"J Rheumatol"},{"issue":"1","key":"3501_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-019-1224-y","volume":"10","author":"ND Noronha","year":"2019","unstructured":"Noronha ND, Mizukami A, Cali\u00e1ri-Oliveira C, Cominal JG, Rocha JL, Covas DT, Swiech K, Malmegrim KC. Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies. Stem Cell Res Ther. 2019;10(1):1\u201321. https:\/\/doi.org\/10.1186\/s13287-019-1224-y.","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"3501_CR15","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41580-018-0028-8","volume":"19","author":"V Haberle","year":"2018","unstructured":"Haberle V, Stark A. Eukaryotic core promoters and the functional basis of transcription initiation. Nat Rev Mol Cell Biol. 2018;19(10):621\u201337.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"3501_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1021\/acssynbio.5b00266","volume":"5","author":"C Ede","year":"2016","unstructured":"Ede C, Chen X, Lin M-Y, Chen YY. Quantitative analyses of core promoters enable precise engineering of regulated gene expression in mammalian cells. ACS Synth Biol. 2016;5(5):395\u2013404. https:\/\/doi.org\/10.1021\/acssynbio.5b00266.","journal-title":"ACS Synth Biol"},{"issue":"10","key":"3501_CR17","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.1093\/nar\/gkx203","volume":"45","author":"S Le Noir","year":"2017","unstructured":"Le Noir S, Boyer F, Lecardeur S, Brousse M, Oruc Z, Cook-Moreau J, et al. Functional anatomy of the immunoglobulin heavy chain 3\u0384 super-enhancer needs not only core enhancer elements but also their unique DNA context. Nucleic Acids Res. 2017;45(10):5829\u201337. https:\/\/doi.org\/10.1093\/nar\/gkx203.","journal-title":"Nucleic Acids Res"},{"issue":"34","key":"3501_CR18","doi-asserted-by":"publisher","first-page":"13925","DOI":"10.1074\/jbc.R116.774745","volume":"292","author":"DS Green","year":"2017","unstructured":"Green DS, Young HA, Valencia JC. Current prospects of type II interferon \u03b3 signaling and autoimmunity. J Biol Chem. 2017;292(34):13925\u201333.","journal-title":"J Biol Chem"},{"issue":"1","key":"3501_CR19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13287-019-1376-9","volume":"10","author":"A Selich","year":"2019","unstructured":"Selich A, Zimmermann K, Tenspolde M, Dittrich-Breiholz O, Von Kaisenberg C, Schambach A, et al. Umbilical cord as a long-term source of activatable mesenchymal stromal cells for immunomodulation. Stem Cell Res Ther. 2019;10(1):285. https:\/\/doi.org\/10.1186\/s13287-019-1376-9.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"3501_CR20","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3390\/cancers12020375","volume":"12","author":"K Zimmermann","year":"2020","unstructured":"Zimmermann K, Kuehle J, Dragon AC, Galla M, Kloth C, Rudek LS, et al. Design and characterization of an \u201cAll-in-One\u201d lentiviral vector system combining constitutive anti-GD2 CAR expression and inducible cytokines. Cancers. 2020;12(2):375.","journal-title":"Cancers"},{"issue":"2","key":"3501_CR21","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.stemcr.2019.06.001","volume":"13","author":"A Selich","year":"2019","unstructured":"Selich A, Ha TC, Morgan M, Falk CS, von Kaisenberg C, Schambach A, Rothe M. Cytokine selection of MSC clones with different functionality. Stem Cell Rep. 2019;13(2):262\u201373.","journal-title":"Stem Cell Rep"},{"issue":"D1","key":"3501_CR22","doi-asserted-by":"publisher","first-page":"D745","DOI":"10.1093\/nar\/gky1113","volume":"47","author":"F Cunningham","year":"2019","unstructured":"Cunningham F, Achuthan P, Akanni W, Allen J, Amode MR, Armean IM, et al. Ensembl 2019. Nucleic Acids Res. 2019;47(D1):D745-51.","journal-title":"Nucleic Acids Res"},{"key":"3501_CR23","doi-asserted-by":"publisher","unstructured":"Galla M, Schambach A, Baum C. Retrovirus-based mRNA transfer for transient cell manipulation. In 2013. p. 139\u201361. Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/978-1-62703-260-5_10.","DOI":"10.1007\/978-1-62703-260-5_10."},{"issue":"2","key":"3501_CR24","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ymthe.2005.08.012","volume":"13","author":"A Schambach","year":"2006","unstructured":"Schambach A, Bohne J, Chandra S, Will E, Margison GP, Williams DA, et al. Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells. Mol Ther. 2006;13(2):391\u2013400. https:\/\/doi.org\/10.1016\/j.ymthe.2005.08.012.","journal-title":"Mol Ther"},{"issue":"9","key":"3501_CR25","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1089\/hum.1995.6.9-1203","volume":"6","author":"Y Yang","year":"1995","unstructured":"Yang Y, Vanin EF, Whitt MA, Fornerod M, Zwart R, Schneiderman RD, et al. Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein. Hum Gene Ther. 1995;6(9):1203\u201313.","journal-title":"Hum Gene Ther"},{"key":"3501_CR26","unstructured":"Wickham H. ggplot2 - Elegant graphics for data analysis (Vol. 35, Issue July). Springer; 2019"},{"issue":"1","key":"3501_CR27","first-page":"S1","volume":"2","author":"N Grabe","year":"2002","unstructured":"Grabe N. AliBaba2: context specific identification of transcription factor binding sites. In Silico Biol. 2002;2(1):S1\u201315.","journal-title":"In Silico Biol"},{"issue":"7","key":"3501_CR28","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"77","key":"3501_CR29","first-page":"1","volume":"3","author":"V G\u00f3mez-Rubio","year":"2017","unstructured":"G\u00f3mez-Rubio V. ggplot2-elegant graphics for data analysis. J Stat Softw. 2017;3(77):1\u20133.","journal-title":"J Stat Softw"},{"issue":"9","key":"3501_CR30","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1164\/rccm.200608-1068OC","volume":"176","author":"W von Wulffen","year":"2007","unstructured":"von Wulffen W, Steinmueller M, Herold S, Marsh LM, Bulau P, Seeger W, et al. Lung dendritic cells elicited by Fms-like Tyrosin 3-kinase ligand amplify the lung inflammatory response to lipopolysaccharide. Am J Respir Crit Care Med. 2007;176(9):892\u2013901. https:\/\/doi.org\/10.1164\/rccm.200608-1068OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3501_CR31","doi-asserted-by":"publisher","first-page":"L58","DOI":"10.1152\/ajplung.2001.280.1.L58","volume":"280","author":"U Maus","year":"2001","unstructured":"Maus U, Herold S, Muth H, Maus R, Ermert L, Ermert M, et al. Monocytes recruited into the alveolar air space of mice show a monocytic phenotype but upregulate CD14. Am J Physiol Cell Mol Physiol. 2001;280(1):L58-68. https:\/\/doi.org\/10.1152\/ajplung.2001.280.1.L58.","journal-title":"Am J Physiol Cell Mol Physiol."},{"issue":"12","key":"3501_CR32","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.1182\/blood-2003-05-1424","volume":"102","author":"OS Kustikova","year":"2003","unstructured":"Kustikova OS, Wahlers A, Ku\u0308hlcke K, Sta\u0308hle B, Zander AR, Baum C, Fehse B,. Dose finding with retroviral vectors: correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population. Blood. 2003;102(12):3934\u20137.","journal-title":"Blood"},{"issue":"13","key":"3501_CR33","doi-asserted-by":"publisher","first-page":"6626","DOI":"10.1128\/JVI.00182-10","volume":"84","author":"JD Suerth","year":"2010","unstructured":"Suerth JD, Maetzig T, Galla M, Baum C, Schambach A. Self-inactivating alpharetroviral vectors with a split-packaging design. J Virol. 2010;84(13):6626\u201335. https:\/\/doi.org\/10.1128\/JVI.00182-10.","journal-title":"J Virol"},{"issue":"3","key":"3501_CR34","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/gt.2012.30","volume":"20","author":"E Merlet","year":"2013","unstructured":"Merlet E, Lipskaia L, Marchand A, Hadri L, Mougenot N, Atassi F, et al. A calcium-sensitive promoter construct for gene therapy. Gene Ther. 2013;20(3):248\u201354.","journal-title":"Gene Ther"},{"issue":"5","key":"3501_CR35","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/gt.2017.20","volume":"24","author":"D Hoffmann","year":"2017","unstructured":"Hoffmann D, Schott JW, Geis FK, Lange L, M\u00fcller F-J, Lenz D, et al. Detailed comparison of retroviral vectors and promoter configurations for stable and high transgene expression in human induced pluripotent stem cells. Gene Ther. 2017;24(5):298\u2013307.","journal-title":"Gene Ther"},{"key":"3501_CR36","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.omtm.2021.04.007","volume":"21","author":"NP Sweeney","year":"2021","unstructured":"Sweeney NP, Vink CA. The impact of lentiviral vector genome size and producer cell genomic to gag-pol mRNA ratios on packaging efficiency and titre. Mol Ther\u2013Methods Clin Dev. 2021;21:574\u201384.","journal-title":"Mol Ther\u2013Methods Clin Dev"},{"issue":"1","key":"3501_CR37","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun S-C. NF-\u03baB signaling in inflammation. Signal Transduct Target Ther. 2017;2(1):17023.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3501_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40164-020-00197-9","volume":"10","author":"Z Wu","year":"2021","unstructured":"Wu Z, Nicoll M, Ingham RJ. AP-1 family transcription factors: a diverse family of proteins that regulate varied cellular activities in classical hodgkin lymphoma and ALK+ ALCL. Exp Hematol Oncol. 2021;10(1):4. https:\/\/doi.org\/10.1186\/s40164-020-00197-9.","journal-title":"Exp Hematol Oncol"},{"key":"3501_CR39","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.12659\/MSM.911184","volume":"25","author":"S Tian","year":"2019","unstructured":"Tian S, Yan Y, Qi X, Li X, Li Z. Treatment of type II collagen-induced rat rheumatoid arthritis model by interleukin 10 (IL10)-mesenchymal stem cells (BMSCs). Med Sci Monit. 2019;25:2923\u201334.","journal-title":"Med Sci Monit"},{"key":"3501_CR40","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12195-019-00608-w","volume":"13","author":"K Cui","year":"2020","unstructured":"Cui K, Chen Y, Zhong H, Wang N, Zhou L, Jiang F. Transplantation of IL-10-overexpressing bone marrow-derived mesenchymal stem cells ameliorates diabetic-induced impaired fracture healing in mice. Cell Mol Bioeng. 2020;13:155\u201363.","journal-title":"Cell Mol Bioeng"},{"key":"3501_CR41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.biomaterials.2015.11.005","volume":"77","author":"W Liao","year":"2016","unstructured":"Liao W, Pham V, Liu L, Riazifar M, Pone EJ, Zhang SX, et al. Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis. Biomaterials. 2016;77:87\u201397.","journal-title":"Biomaterials"},{"key":"3501_CR42","doi-asserted-by":"publisher","first-page":"106212","DOI":"10.1016\/j.intimp.2020.106212","volume":"81","author":"M Shao","year":"2020","unstructured":"Shao M, Wang D, Zhou Y, Du K, Liu W. Interleukin-10 delivered by mesenchymal stem cells attenuates experimental autoimmune myocarditis. Int Immunopharmacol. 2020;81:106212.","journal-title":"Int Immunopharmacol"},{"issue":"14","key":"3501_CR43","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1182\/blood-2013-04-495119","volume":"122","author":"O Levy","year":"2013","unstructured":"Levy O, Zhao W, Mortensen LJ, Leblanc S, Tsang K, Fu M, et al. mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation. Blood. 2013;122(14):e23-32.","journal-title":"Blood"},{"issue":"4","key":"3501_CR44","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1073\/pnas.88.4.1172","volume":"88","author":"P Vieira","year":"1991","unstructured":"Vieira P, de Waal-Malefyt R, Dang MN, Johnson KE, Kastelein R, Fiorentino DF, et al. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci. 1991;88(4):1172\u20136. https:\/\/doi.org\/10.1073\/pnas.88.4.1172.","journal-title":"Proc Natl Acad Sci."},{"issue":"9","key":"3501_CR45","doi-asserted-by":"publisher","first-page":"4476","DOI":"10.4049\/jimmunol.1103346","volume":"188","author":"K Steinwede","year":"2012","unstructured":"Steinwede K, Maus R, Bohling J, Voedisch S, Braun A, Ochs M, et al. Contribute to lung-protective immunity against mycobacterial infections in mice. J Immunol. 2012;188(9):4476\u201387. https:\/\/doi.org\/10.4049\/jimmunol.1103346.","journal-title":"J Immunol"},{"issue":"1","key":"3501_CR46","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000047856","volume":"169","author":"J Gao","year":"2001","unstructured":"Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs. 2001;169(1):12\u201320.","journal-title":"Cells Tissues Organs"},{"issue":"1","key":"3501_CR47","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12967-018-1541-4","volume":"16","author":"Y Yang","year":"2018","unstructured":"Yang Y, He X, Zhao R, Guo W, Zhu M, Xing W, et al. Serum IFN-\u03b3 levels predict the therapeutic effect of mesenchymal stem cell transplantation in active rheumatoid arthritis. J Transl Med. 2018;16(1):165. https:\/\/doi.org\/10.1186\/s12967-018-1541-4.","journal-title":"J Transl Med"},{"issue":"5","key":"3501_CR48","doi-asserted-by":"publisher","first-page":"591","DOI":"10.5966\/sctm.2015-0176","volume":"5","author":"A Selich","year":"2016","unstructured":"Selich A, Daudert J, Hass R, Philipp F, Von Kaisenberg C, Paul G, et al. Massive clonal selection and transiently contributing clones during expansion of mesenchymal stem cell cultures revealed by lentiviral RGB-barcode technology. Stem Cells Transl Med. 2016;5(5):591\u2013601.","journal-title":"Stem Cells Transl Med"},{"issue":"35","key":"3501_CR49","doi-asserted-by":"publisher","first-page":"e2105972118","DOI":"10.1073\/pnas.2105972118","volume":"118","author":"BJ Kwee","year":"2021","unstructured":"Kwee BJ, Lam J, Akue A, KuKuruga MA, Zhang K, Gu L, et al. Functional heterogeneity of IFN-\u03b3\u2013licensed mesenchymal stromal cell immunosuppressive capacity on biomaterials. Proc Natl Acad Sci. 2021;118(35):e2105972118. https:\/\/doi.org\/10.1073\/pnas.2105972118.","journal-title":"Proc Natl Acad Sci"},{"key":"3501_CR50","doi-asserted-by":"crossref","unstructured":"Ali T, Renkawitz R, Bartkuhn M. Insulators and domains of gene expression [Internet]. Vol. 37, Current opinion in genetics and development. Elsevier current trends; 2016 [cited 2019 Mar 14]. p. 17\u201326. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0959437X1500132X#!.","DOI":"10.1016\/j.gde.2015.11.009"},{"key":"3501_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2016.140","author":"Y Liao","year":"2016","unstructured":"Liao Y, Lei J, Liu M, Lin W, Hong D, Tuo Y, et al. Mesenchymal stromal cells mitigate experimental colitis via insulin-like growth factor binding protein 7 -mediated immunosuppression. Mol Ther. 2016. https:\/\/doi.org\/10.1038\/mt.2016.140.","journal-title":"Mol Ther"},{"issue":"12","key":"3501_CR52","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1038\/s41422-021-00573-y","volume":"31","author":"R Zhu","year":"2021","unstructured":"Zhu R, Yan T, Feng Y, Liu Y, Cao H, Peng G, Yang Y, Xu Z, Liu J, Hou W, Wang X. Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms. Cell Res. 2021;31(12):1244\u201362.","journal-title":"Cell Res"},{"issue":"3","key":"3501_CR53","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","volume":"20","author":"C Raffin","year":"2020","unstructured":"Raffin C, Vo LT, Bluestone JA. Treg cell-based therapies: challenges and perspectives. Nat Rev Immunol. 2020;20(3):158\u201372.","journal-title":"Nat Rev Immunol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-023-03501-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-023-03501-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-023-03501-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T11:39:07Z","timestamp":1700393947000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-023-03501-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,23]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3501"],"URL":"https:\/\/doi.org\/10.1186\/s13287-023-03501-6","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,23]]},"assertion":[{"value":"3 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human UC was obtained from full term deliveries (38\u201340\u00a0weeks) of healthy mothers after written informed consent, in accordance with the Helsinki Declaration of 1975 (revised in 1983) and approved by the Hannover Medical School Ethics Committee on 16th July, 2015 (Viral gene transfer in umbilical cord tissue and blood, 2791-2015). Animal experiments with the title \u201cOrientation study for the use of genetically-modified mesenchymal stromal cells for acute lung injuries\u201d were approved by the supervising animal research review board at Hannover Medical School and the Lower Saxony State Office for Consumer Protection and Food Safety on February 2, 2022 (21\/3773).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors do not have any disclosures or conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"270"}}